Medtronic (MDT) Tops Q1 EPS by 1c; Offers FY23 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $95.41 -1.22%
EPS Growth %: -2.2%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -2.2%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q1 EPS of $1.13, $0.01 better than the analyst estimate of $1.12. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $7.22 billion.
GUIDANCE:
Medtronic sees FY2023 EPS of $5.53-$5.65, versus the consensus of $5.56.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Investing.com’s stocks of the week
- Goldman Sachs sees US stocks dip on tech earnings and macro shifts
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
